Publicaciones en las que colabora con Guillermo Quintás Soriano (19)

2024

  1. Assessing ATR-FTIR spectroscopy for steatosis quantification in liver biopsies in a long-duration cross-sectional study

    Microchemical Journal, Vol. 198

  2. Cluster-Partial Least Squares (c-PLS) regression analysis: Application to miRNA and metabolomic data

    Analytica chimica acta, Vol. 1286, pp. 342052

  3. Corrigendum to “Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support” [Biomed. Pharmacother. 174 (2024) 116530] (Biomedicine & Pharmacotherapy (2024) 174, (S0753332224004141), (10.1016/j.biopha.2024.116530))

    Biomedicine and Pharmacotherapy

  4. Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

  5. Improving insights from metabolomic functional analysis combining multivariate tools

    Analytica Chimica Acta, Vol. 1323

  6. Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support

    Biomedicine and Pharmacotherapy, Vol. 174

  7. Progress and challenges of mid-infrared spectroscopy for liver characterization focusing on steatosis, fibrosis and cancer

    Applied Spectroscopy Reviews, Vol. 59, Núm. 4, pp. 578-599

2023

  1. Analysis of longitudinal metabolomic data using multivariate curve resolution-alternating least squares and pathway analysis

    Chemometrics and Intelligent Laboratory Systems, Vol. 232

  2. Enhancing the accuracy of mid-infrared spectroscopy-based liver steatosis quantification using digital image analysis as a reference

    Analyst, Vol. 148, Núm. 13, pp. 3097-3106

  3. Metabolomic Diversity of Human Milk Cells over the Course of Lactation—A Preliminary Study

    Nutrients, Vol. 15, Núm. 5

  4. Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved

    Archives of Toxicology, Vol. 97, Núm. 6, pp. 1723-1738

  5. The assessment of the potential hepatotoxicity of new drugs by in vitro metabolomics

    Frontiers in Pharmacology, Vol. 14

2022

  1. A Novel UPLC-MS Metabolomic Analysis-Based Strategy to Monitor the Course and Extent of iPSC Differentiation to Hepatocytes

    Journal of Proteome Research, Vol. 21, Núm. 3, pp. 702-712

  2. The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment

    Metabolites, Vol. 12, Núm. 6

  3. The effect of Holder pasteurization on the lipid and metabolite composition of human milk

    Food Chemistry, Vol. 384

2021

  1. Analysis of the Association between Fatigue and the Plasma Lipidomic Profile of Inflammatory Bowel Disease Patients

    Journal of proteome research, Vol. 20, Núm. 1, pp. 381-392

  2. Extracting consistent biological information from functional results of metabolomic pathway analysis using the Mantel's test

    Analytica Chimica Acta, Vol. 1187

  3. Factors that influence the quality of metabolomics data in in vitro cell toxicity studies: a systematic survey

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Comparing targeted vs. untargeted MS2 data-dependent acquisition for peak annotation in LC–MS metabolomics

    Metabolites, Vol. 10, Núm. 4